Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
Piotr Lewczuk(Universitätsklinikum Erlangen), Charlotte E. Teunissen(Amsterdam Neuroscience), Olga Kofanova(Central Bank of Luxembourg), Kaj Blennow(Sahlgrenska University Hospital), Dominik Strapagiel(University of Łódź), Amélie Gaignaux(Central Bank of Luxembourg), Fay Betsou(Institut Pasteur), Silvia Paciotti(University of Perugia), Johannes Kornhuber(Friedrich-Alexander-Universität Erlangen-Nürnberg), Barbara Mroczko(Medical University of Białystok), Natalia Ermann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sebastian Brandner(Universitätsklinikum Erlangen), Michael H. A. Roehrl(Beth Israel Deaconess Medical Center), Sandra Mendoza, Jonathan Vogelgsang(Harvard University)
Cited by 17
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k